
Africa imports most of the enzymes and recombinant proteins used by its industries. Developing local manufacturing capacity presents an opportunity for African biotechnology companies to reduce this dependence.
At an African STARS seminar hosted by the Centre for Epidemic Response and Innovation (CERI) at Stellenbosch University on 29 October 2026, Dominic Nicholas, co-founder and CEO of Immobazyme, shared the South African company's journey of finding the right market fit, from sugar processing to nutraceuticals.
Founded in 2019 by Nicholas, Nick Enslin, and Ethan Hunter, Immobazyme develops recombinant proteins for industrial, cosmetic, food, and pharmaceutical applications. Its progress includes achieving ISO 22000 certification, supplying its Solulase™ product across four continents, conducting a customer-funded field trial, and designing a production cleanroom.
Nicholas also reflected on lessons learned in establishing the business. Initially, the founders tried to conserve limited funding by doing much of the work themselves, but discovered the value of investing in experienced professionals and giving them the resources and freedom to succeed.
Another important lesson was understanding customers' regulatory requirements early. A technically successful product was not enough. Food safety certification, halal or kosher compliance, and laboratory testing documentation were also essential to accessing markets.
A Stellenbosch University MSc Microbiology graduate, Nicholas is overseeing the development of a 1,800 m² manufacturing facility to support Immobazyme's expansion.
Hosted by Dr Richard Gordon, the seminar formed part of the African STARS Seminar Series, which connects fellows with leaders working across Africa's science, health, and biotechnology sectors.
Watch the seminar recording here: https://youtu.be/2goIlypd6zM
News date: 2026-11-04
Links:
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).
Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira